ClinicalTrials.gov
public full text
Public Domain
Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors
A Phase 1/2a Open-Label Dose Escalation and Dose Expansion Study of T3011 when Administered Intravenously as a Single Agent and in Combination with Other Therapy in Subjects with Advanced Solid Tumors
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Dose Escalation Trial of BNT152+153 in Patients With Cancer#867558
- A Study With ABL103 in Subjects With Advanced or Metastatic Solid Tumors#810101
- Study of Tinostamustine for Adjuvant Treatment of Glioblastoma#994628
- INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors#1162717
- Ph Ib/BGJ398/Cervix and Other Solid Tumors#917207
Record · ID 1085316
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive